GRN and breast cancer: Here, we investigated how progranulin treatment affected the secretion of other cytokines, and specifically the secretion mediated via the sortilin receptor, by analyzing conditioned media from MCF7 (estrogen receptor alpha; ERα positive) and MDA-MB-231 (ERα negative) breast cancer cells.